Skip to main content
. 2015 Jul 29;10(7):e0134349. doi: 10.1371/journal.pone.0134349

Fig 4. Incremental Percent Improvement in Abdominal Bloating at Week 12.

Fig 4

Intent-to-treat Population; % improvement in abdominal bloating at week 12 (end of the treatment period). Note: The distribution of % improvement in abdominal bloating at week 12 was a secondary endpoint for both linaclotide dose groups. (P < 0.01 for both linaclotide groups vs. placebo; P values were obtained from a Kolmogorov-Smirnov test for equality of distribution.)